Novartis Closer to Selling Copy of Amgen's Neupogen

A federal appeals court in Washington denied Amgen Inc.’s request for a temporary injunction to block Novartis AG from selling a copycat version of the blockbuster drug Neupogen in the U.S.

from WSJ.com: US Business http://ift.tt/1JOcOwP
via IFTTT